Chlamydia Vaccines 2023

Authored by
Last reviewed
February 22, 2023
Content Overview
Chlamydia is a common STD among women. Currently no U.S. FDA-approved vaccine is available to prevent chlamydia infection.

Chlamydia Vaccines 2023

There is no U.S. Food and Drug Administration (FDA) vaccine available to prevent chlamydia infection. However, if undetected or left untreated, Chlamydia represents a significant cause of pelvic inflammatory disease and infertility in women.

Chlamydia Vaccine Candidates

Blue Water Vaccines Inc. is developing a live attenuated, oral Chlamydia vaccine candidate.

LinKinVax, linked to the Vaccine Research Institute, is conducting pre-clinical research on the Anti.CD40.chlamydia vaccine candidate.

Chlamydia Treatments

February 20, 2023 - Researchers from the University of Washington, Kenya Medical Research Institute, and Hennepin Healthcare Research Institute announced results from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (Chlamydia or gonorrhea) among women.